Timing is everything: could your body clock influence lung cancer?

NCT ID NCT05988970

Completed Knowledge-focused Sponsor: Institut Claudius Regaud Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether the time of day affects the number of cancer cells in the blood of people with advanced lung cancer. Researchers took blood samples from 27 patients at 4 a.m. and 10 a.m. before starting treatment. The goal was to see if circadian rhythms influence how cancer spreads, which could one day help time treatments for better effect.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors understand the best time of day to treat lung cancer to reduce the risk of cancer spreading.
What could go wrong: This is a very small pilot study with only 27 participants, so results may not apply to all lung cancer patients. It is designed to gather information, not to test a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm Neoplastic Cells, Circulating non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER

Contacts and locations

Locations

Hôpital Larrey

Toulouse, France
Institut Universitaire du Cancer de Toulouse - Oncopole

Toulouse, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.